Syndromic Testing

Molecular syndromic tests allow the detection of microorganisms, which are most commonly responsible for infectious diseases, in a single test. These tests include analyzes that simultaneously detect and identify multiple pathogens associated with clinical syndromes such as blood circulation, respiratory tract, gastrointestinal and central nervous system infections. Existing tests within the Bio-Speedy® Syndromic Panels offer the potential for a definitive diagnosis in about 1 hour. This enables healthcare providers to quickly identify specific infections and to make timely clinical management decisions (eg hospitalization, isolation and antimicrobial treatment or lack thereof).

Symptoms of infectious neurological disorder may not indicate a specific agent. The isolation of the agent by conventional methods is difficult and takes a long time. A prompt and accurate diagnosis of the agent is necessary for appropriate treatment. Biospeedy® Meningitis & Encephalitis qPCR Panel which is qPCR and RT-qPCR based method with 10 ^ 1 / ml detection limit, > 98% sensitivity and > 97% specificity allows faster results than conventional methods and thus allows clinicians to treat patients correctly. Biospeedy® Meningitis & Encephalitis qPCR Panel is developed for diagnosis of bacterial meningitis agents, viral meningitis agents and fungal meningitis agents from cerebrospinal fluid.

Biospeedy® Bacterial Meningitis & Encephalitis Multiplex qPCR Kit

Catalog No: BS-SP-BME-80-100

Biospeedy® Viral Meningitis & Encephalitis Multiplex qPCR Kit

Catalog No: BS-SP-VME-81-100

Biospeedy® Fungal Meningitis & Encephalitis Multiplex qPCR Kit

Catalog No: BS-SP-FME-79-100

Learn more

Respiratory tract infection has been associated with high morbidity and mortality worldwide, and its symptoms may not indicate a particular causative agent. Early and accurate diagnosis of pathogens causing respiratory infections is important with appropriate antiviral or antibacterial therapy, initiating effective infection control measures and reducing hospital stay. Biospeedy® Respiratory System qPCR Panel allows detection / identification of viruses that cannot be routinely detected by conventional methods. Biospeedy® Respiratory System qPCR Panel is qPCR and RT-qPCR based method, and nasopharyngeal aspirate / lavage, bronchoalveolar lavage, nasopharyngeal swab, oropharyngeal swab and sputum samples can be analyzed.

Biospeedy® Viral Respiratory System Infections Multiplex qPCR Kit

Catalog No: BS-SY-301-100

Biospeedy® Bacterial Respiratory System Infections Multiplex qPCR Kit

Catalog No: BS-SP-BRT-83-100

Learn more

Symptoms of gastroenteritis may not indicate a specific agent. The number of possible etiological agents is very large and includes viruses, bacteria, protozoas. The isolation of the agent by conventional methods is difficult and takes a long time. Biospeedy® Gastroenteritis qPCR Panel allows faster results than conventional methods from stool and rectal swab samples and thus allows clinicians to treat patients correctly. Biospeedy® Gastroenteritis qPCR Panel is qPCR and RT-qPCR based method with 10 ^ 1-10 ^ 2 / ml detection limit, > 94% sensitivity and > 98% specificity.

Biospeedy® Bacterial Gastroenteritis Multiplex qPCR Kit

Catalog No: BS-SP-BG-71-100

Biospeedy® Parasitic Gastroenteritis Multiplex qPCR Kit

Catalog No: BS-SP-PG-72-100

Biospeedy® Viral Gastroenteritis Multiplex qPCR Kit

Catalog No: BS-SP-VG-73-100

Learn more

Proper treatment and rapid recovery are possible by early diagnosis of sepsis. The chance of survival in sepsis decreases abruptly as the onset of treatment is delayed. If a patient receives the correct antimicrobial treatment in the first hour of diagnosis, the chance of survival is close to 80%; this rate decreases by 7.6% for each delayed hour. Biospeedy® Sepsis qPCR Panel detect fungal sepsis agents, gram negative sepsis bacteria agents, antibiotic resistance agents and gram positive sepsis bacteria agents specifically and allows clinicians to promptly and accurately treat patients. Biospeedy® Sepsis qPCR Panel is qPCR and RT-qPCR based method with has 1 / ml detection limit, > 97% sensitivity and > 98% specificity for blood culture samples. Biospeedy® Sepsis qPCR Panel has detection limit of 10 ^ 1-10 ^ 2 / ml, > 82% sensitivity and > 98% in the blood sample.

Biospeedy® Fungal Sepsis Multiplex qPCR Kit

Catalog No: BS-SP-FSE-93-100

Biospeedy® Gram Negative Bacteria qPCR Kit

Catalog No: BS-SP-GNB-88-100

Biospeedy® CRE qPCR Screening Kit

Catalog No: BS-HE-403-100

Biospeedy® Colistin resistance Real-Time PCR Detection Kit

Catalog No: BS-SP-MCR-26-100

Biospeedy® MRSA qPCR Screening Kit

Catalog No: BS-HE-401-100

Biospeedy® VRE qPCR Screening Kit

Catalog No: BS-HE-402-100

Biospeedy® Gram Positive Bacteria qPCR Kit

Catalog No: BS-SP-GPB-92-100

Learn more

Related Products

VETERINARY DIAGNOSTIC TEST KITS
CLINICAL MICROBIOLOGY
FOOD & WATER SAFETY
RINA M14 NUCLEIC ACID ISOLATION ROBOT